Literature DB >> 3875798

Stimulation of multipotential, erythroid and other murine haematopoietic progenitor cells by adherent cell lines in the absence of detectable multi-CSF (IL-3).

C L Li, G R Johnson.   

Abstract

It is well established that murine multipotential and committed erythroid progenitor cells require the presence of a glycoprotein, termed multi-CSF (multi-colony-stimulating factor, IL-3) for clonal proliferation and differentiation in vitro. The initial proliferation of these cells can also be stimulated by two other glycoproteins, granulocyte-macrophage CSF (GM-CSF) and granulocyte CSF (G-CSF), although continued proliferation and differentiation requires the subsequent presence of multi-CSF. Here we report the stimulation of multipotential, erythroid and other haematopoietic progenitor cells by a number of adherent cell lines including a cloned bone marrow cell line (B.Ad). The positive cell lines, as feeder layers, exhibit colony-stimulating, erythropoietin-like and burst-promoting (BPA) activities. Optimal erythropoietic stimulation by the B.Ad line requires close cell-cell contact. The cell lines also support the in vitro clonal growth of multipotential colony-forming cells and progenitors of six other haematopoietic lineages. The biological activities observed seem not to be mediated by known multipotential or erythroid colony-stimulating factors (multi-CSF, IL-3, MCGF, HCGF, PSF, BPA).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875798     DOI: 10.1038/316633a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  9 in total

1.  Establishment of an adherent cell feeder layer from human umbilical cord blood for support of long-term hematopoietic progenitor cell growth.

Authors:  Z Q Ye; J K Burkholder; P Qiu; J C Schultz; N T Shahidi; N S Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

2.  In vitro-derived leukemic erythroid cell lines induced by a raf- and myc-containing retrovirus differentiate in response to erythropoietin.

Authors:  S P Klinken; N A Nicola; G R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Presence of a very small population of Thy-1+, L3T4+ cells producing large amounts of IL-3 in young athymic nude mice.

Authors:  M Kimoto; S de Kossodo; V Kindler; M Detraz; P Vassalli; S Izui
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

4.  Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.

Authors:  J Brandt; E F Srour; K van Besien; R A Briddell; R Hoffman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

5.  Response of simian virus 40 (SV40)-transformed, cultured human marrow stromal cells to hematopoietic growth factors.

Authors:  J Nemunaitis; D F Andrews; C Crittenden; K Kaushansky; J W Singer
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

6.  Establishment and characterization of stromal cell lines that support differentiation of murine hematopoietic blast cells into osteoclast-like cells.

Authors:  H Takanashi; T Matsuishi; K Yoshizato
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-06       Impact factor: 2.416

7.  Generation of murine stromal cell lines supporting hematopoietic stem cell proliferation by use of recombinant retrovirus vectors encoding simian virus 40 large T antigen.

Authors:  D A Williams; M F Rosenblatt; D R Beier; R D Cone
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

8.  Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages.

Authors:  K Kongsuwan; E Webb; P Housiaux; J M Adams
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

9.  Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors.

Authors:  K Nocka; J Buck; E Levi; P Besmer
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.